The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma

References

• Andriani F, Garfield J, Fusenig NE, Garlick JA. Basement membrane proteins promote progression of intraepithelial neoplasia in 3-dimensional models of human stratified epithelium. Int J Cancer 2004; 108:348 - 57; http://dx.doi.org/10.1002/ijc.11525; PMID: 14648700
   PubMed Web of Science ®Google Scholar
• Margulis A, Zhang W, Alt-Holland A, Pawagi S, Prabhu P, Cao J, et al. Loss of intercellular adhesion activates a transition from low- to high-grade human squamous cell carcinoma. Int J Cancer 2006; 118:821 - 31; http://dx.doi.org/10.1002/ijc.21409; PMID: 16152579
   PubMed Web of Science ®Google Scholar
• Andriani F, Garfield J, Fusenig NE, Garlick JA. Basement membrane proteins promote progression of intraepithelial neoplasia in 3-dimensional models of human stratified epithelium. Int J Cancer 2004; 108:348 - 57; http://dx.doi.org/10.1002/ijc.11525; PMID: 14648700
   PubMed Web of Science ®Google Scholar
• Itano N, Zhuo L, Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci 2008; 99:1720 - 5; http://dx.doi.org/10.1111/j.1349-7006.2008.00885.x; PMID: 18564137
   PubMed Web of Science ®Google Scholar
• Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007; 101:805 - 15; http://dx.doi.org/10.1002/jcb.21159; PMID: 17226777
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1:46 - 54; http://dx.doi.org/10.1038/35094059; PMID: 11900251
   PubMed Web of Science ®Google Scholar
• Ziober AF, Falls EM, Ziober BL. The extracellular matrix in oral squamous cell carcinoma: friend or foe?. Head Neck 2006; 28:740 - 9; http://dx.doi.org/10.1002/hed.20382; PMID: 16649214
   PubMed Web of Science ®Google Scholar
• Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci USA 2008; 105:12979 - 84; http://dx.doi.org/10.1073/pnas.0806437105; PMID: 18753622
   PubMed Web of Science ®Google Scholar
• Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727 - 32; http://dx.doi.org/10.1074/jbc.275.4.2727; PMID: 10644736
   PubMed Web of Science ®Google Scholar
• Alt-Holland A, Shamis Y, Riley KN, DesRochers TM, Fusenig NE, Herman IM, et al. E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. J Invest Dermatol 2008; 128:2498 - 507; http://dx.doi.org/10.1038/jid.2008.102; PMID: 18528437
   PubMed Web of Science ®Google Scholar
• Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat 1993; 24:175 - 84; http://dx.doi.org/10.1007/BF01833258; PMID: 8435473
   PubMed Web of Science ®Google Scholar
• Birchmeier W, Hulsken J, Behrens J. E-cadherin as an invasion suppressor. Ciba Found Symp 1995; 189:124 - 36; PMID: 7587628
   PubMedGoogle Scholar
• Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res 2005; 65:1783 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-04-3399; PMID: 15753375
   PubMed Web of Science ®Google Scholar
• Zschiesche W, Schonborn I, Behrens J, Herrenknecht K, Hartveit F, Lilleng P, et al. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res 1997; 17:561 - 7; PMID: 9066580
   PubMed Web of Science ®Google Scholar
• Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12:247 - 56; PMID: 20173740
   PubMed Web of Science ®Google Scholar
• Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006; 42:190 - 200; http://dx.doi.org/10.1016/j.oraloncology.2005.07.010; PMID: 16249116
   PubMed Web of Science ®Google Scholar
• Supić G, Kozomara R, Brankovic-Magic M, Jovic N, Magic Z. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 2009; 45:1051 - 7; http://dx.doi.org/10.1016/j.oraloncology.2009.07.007; PMID: 19665921
   PubMed Web of Science ®Google Scholar
• Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006; 7:77 - 82; http://dx.doi.org/10.1016/S1470-2045(05)70540-4; PMID: 16389187
   PubMed Web of Science ®Google Scholar
• Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35:589 - 94; http://dx.doi.org/10.1111/j.1600-0714.2006.00474.x; PMID: 17032390
   PubMed Web of Science ®Google Scholar
• Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006; 6:48; http://dx.doi.org/10.1186/1471-2407-6-48; PMID: 16512896
   PubMed Web of Science ®Google Scholar
• Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55:5195 - 9; PMID: 7585573
   PubMed Web of Science ®Google Scholar
• Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, et al. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 1998; 58:1972 - 7; PMID: 9581841
   PubMed Web of Science ®Google Scholar
• Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 2006; 94:661 - 71; PMID: 16495925
   PubMed Web of Science ®Google Scholar
• Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 2004; 3:28; http://dx.doi.org/10.1186/1476-4598-3-28; PMID: 15476557
   PubMed Web of Science ®Google Scholar
• Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35:589 - 94; http://dx.doi.org/10.1111/j.1600-0714.2006.00474.x; PMID: 17032390
   PubMed Web of Science ®Google Scholar
• Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol 2007; 52:740 - 7; http://dx.doi.org/10.1016/j.archoralbio.2007.01.013; PMID: 17331461
   PubMed Web of Science ®Google Scholar
• Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J Pathol 2000; 190:15 - 9; http://dx.doi.org/10.1002/(SICI)1096-9896(200001)190:1<15::AID-PATH489>3.0.CO;2-L; PMID: 10640987
   PubMed Web of Science ®Google Scholar
• Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003; 5:R217 - 22; http://dx.doi.org/10.1186/bcr651; PMID: 14580257
   PubMed Web of Science ®Google Scholar
• Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 2010; 9:179; http://dx.doi.org/10.1186/1476-4598-9-179; PMID: 20609236
   PubMed Web of Science ®Google Scholar
• Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727 - 32; http://dx.doi.org/10.1074/jbc.275.4.2727; PMID: 10644736
   PubMed Web of Science ®Google Scholar
• Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51:6328 - 37; PMID: 1933895
   PubMed Web of Science ®Google Scholar
• Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007; 101:816 - 29; http://dx.doi.org/10.1002/jcb.21215; PMID: 17243120
   PubMed Web of Science ®Google Scholar
• Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008; 25:621 - 8; http://dx.doi.org/10.1007/s10585-008-9167-1; PMID: 18600305
   PubMed Web of Science ®Google Scholar
• Alt-Holland A, Shamis Y, Riley KN, DesRochers TM, Fusenig NE, Herman IM, et al. E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. J Invest Dermatol 2008; 128:2498 - 507; http://dx.doi.org/10.1038/jid.2008.102; PMID: 18528437
   PubMed Web of Science ®Google Scholar
• Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res 2005; 65:1783 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-04-3399; PMID: 15753375
   PubMed Web of Science ®Google Scholar
• Alt-Holland A, Zhang W, Margulis A, Garlick JA. Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Semin Cancer Biol 2005; 15:84 - 96; http://dx.doi.org/10.1016/j.semcancer.2004.08.007; PMID: 15652453
   PubMed Web of Science ®Google Scholar
• Kudo Y, Kitajjma S, Sato S, Miyauchi M, Ogawa I, Takata T. Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis. Oral Oncol 2003; 39:515 - 20; http://dx.doi.org/10.1016/S1368-8375(03)00015-0; PMID: 12747977
   PubMed Web of Science ®Google Scholar
• Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004; 10:5455 - 63; http://dx.doi.org/10.1158/1078-0432.CCR-04-0372; PMID: 15328184
   PubMed Web of Science ®Google Scholar
• Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, et al. Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther 2007; 6:391 - 403; http://dx.doi.org/10.1158/1535-7163.MCT-06-0609; PMID: 17272646
   PubMed Web of Science ®Google Scholar
• Sen GL, Webster DE, Barragan DI, Chang HY, Khavari PA. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev 2008; 22:1865 - 70; http://dx.doi.org/10.1101/gad.1673508; PMID: 18628393
   PubMed Web of Science ®Google Scholar
• Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40:741 - 50; http://dx.doi.org/10.1038/ng.159; PMID: 18488029
   PubMed Web of Science ®Google Scholar
• Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232 - 6; http://dx.doi.org/10.1038/ng1950; PMID: 17200670
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315 - 26; http://dx.doi.org/10.1016/j.cell.2006.02.041; PMID: 16630819
   PubMed Web of Science ®Google Scholar
• Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237 - 42; http://dx.doi.org/10.1038/ng1972; PMID: 17211412
   PubMed Web of Science ®Google Scholar
• Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA 2008; 14:872 - 7; http://dx.doi.org/10.1261/rna.972008; PMID: 18367714
   PubMed Web of Science ®Google Scholar
• Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010; 184:6773 - 81; http://dx.doi.org/10.4049/jimmunol.0904060; PMID: 20483747
   PubMed Web of Science ®Google Scholar
• Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010; 51:881 - 90; PMID: 20146264
   PubMed Web of Science ®Google Scholar
• Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727 - 32; http://dx.doi.org/10.1074/jbc.275.4.2727; PMID: 10644736
   PubMed Web of Science ®Google Scholar
• Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients. [seecomments] J Pathol 2000; 190:15 - 9; http://dx.doi.org/10.1002/(SICI)1096-9896(200001)190:1<15::AID-PATH489>3.0.CO;2-L; PMID: 10640987
   PubMed Web of Science ®Google Scholar
• Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 2008; 105:14867 - 72; http://dx.doi.org/10.1073/pnas.0807146105; PMID: 18806226
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1:46 - 54; http://dx.doi.org/10.1038/35094059; PMID: 11900251
   PubMed Web of Science ®Google Scholar
• Alt-Holland A, Zhang W, Margulis A, Garlick JA. Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Semin Cancer Biol 2005; 15:84 - 96; http://dx.doi.org/10.1016/j.semcancer.2004.08.007; PMID: 15652453
   PubMed Web of Science ®Google Scholar
• Eriksen JG, Steiniche T, Sogaard H, Overgaard J. Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck. APMIS 2004; 112:560 - 8; http://dx.doi.org/10.1111/j.1600-0463.2004.apm1120902.x; PMID: 15601304
   PubMed Web of Science ®Google Scholar
• Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35:589 - 94; http://dx.doi.org/10.1111/j.1600-0714.2006.00474.x; PMID: 17032390
   PubMed Web of Science ®Google Scholar
• Bukholm IK, Nesland JM, Borresen-Dale AL. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J Pathol 2000; 190:15 - 9; http://dx.doi.org/10.1002/(SICI)1096-9896(200001)190:1<15::AID-PATH489>3.0.CO;2-L; PMID: 10640987
   PubMed Web of Science ®Google Scholar
• Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14:79 - 89; http://dx.doi.org/10.1016/j.ccr.2008.06.005; PMID: 18598946
   PubMed Web of Science ®Google Scholar
• Weinberg RA. Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 2008; 10:1021 - 3; http://dx.doi.org/10.1038/ncb0908-1021; PMID: 18758491
   PubMed Web of Science ®Google Scholar
• Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007; 101:816 - 29; http://dx.doi.org/10.1002/jcb.21215; PMID: 17243120
   PubMed Web of Science ®Google Scholar
• Ateeq B, Unterberger A, Szyf M, Rabbani SA. Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo. Neoplasia 2008; 10:266 - 78; PMID: 18320071
   PubMed Web of Science ®Google Scholar
• Chik F, Szyf M. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors. Carcinogenesis 2011; 32:224 - 32; http://dx.doi.org/10.1093/carcin/bgq221; PMID: 20980350
   PubMed Web of Science ®Google Scholar
• Frost P, Kerbel RS, Hunt B, Man S, Pathak S. Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2'-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression. Cancer Res 1987; 47:2690 - 5; PMID: 2436755
   PubMed Web of Science ®Google Scholar
• Yu Y, Zeng P, Xiong J, Liu Z, Berger SL, Merlino G. Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene. PLoS One 2010; 5:e12710; http://dx.doi.org/10.1371/journal.pone.0012710; PMID: 20856924
   PubMed Web of Science ®Google Scholar
• Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237 - 42; http://dx.doi.org/10.1038/ng1972; PMID: 17211412
   PubMed Web of Science ®Google Scholar
• Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39:157 - 8; http://dx.doi.org/10.1038/ng1941; PMID: 17200673
   PubMed Web of Science ®Google Scholar
• Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, et al. Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther 2007; 6:391 - 403; http://dx.doi.org/10.1158/1535-7163.MCT-06-0609; PMID: 17272646
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315 - 26; http://dx.doi.org/10.1016/j.cell.2006.02.041; PMID: 16630819
   PubMed Web of Science ®Google Scholar
• Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237 - 42; http://dx.doi.org/10.1038/ng1972; PMID: 17211412
   PubMed Web of Science ®Google Scholar
• Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123 - 36; http://dx.doi.org/10.1101/gad.381706; PMID: 16618801
   PubMed Web of Science ®Google Scholar
• Issa JP, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res 2009; 15:3938 - 46; http://dx.doi.org/10.1158/1078-0432.CCR-08-2783; PMID: 19509174
   PubMed Web of Science ®Google Scholar
• Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727 - 32; http://dx.doi.org/10.1074/jbc.275.4.2727; PMID: 10644736
   PubMed Web of Science ®Google Scholar
• Benton G, Crooke E, George J. Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status. FASEB J 2009; 23:3884 - 95; http://dx.doi.org/10.1096/fj.08-128702; PMID: 19635753
   PubMed Web of Science ®Google Scholar
• Tseng CW, Lin CC, Chen CN, Huang HC, Juan HF. Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC Syst Biol 2011; 5:99; http://dx.doi.org/10.1186/1752-0509-5-99; PMID: 21703006
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010; 14:1170 - 9; http://dx.doi.org/10.1007/s11605-010-1202-2; PMID: 20422307
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010; 14:1170 - 9; http://dx.doi.org/10.1007/s11605-010-1202-2; PMID: 20422307
   PubMed Web of Science ®Google Scholar
• Deng S, Calin GA, Croce CM, Coukos G, Zhang L. Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008; 7:2643 - 6; http://dx.doi.org/10.4161/cc.7.17.6597; PMID: 18719391
   PubMed Web of Science ®Google Scholar
• Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 2010; 56:1107 - 18; http://dx.doi.org/10.1373/clinchem.2010.144709; PMID: 20431052
   PubMed Web of Science ®Google Scholar
• Kumaki Y, Oda M, Okano M. QUMA: quantification tool for methylation analysis. Nucleic Acids Res 2008; 36:W170 - 5; http://dx.doi.org/10.1093/nar/gkn294; PMID: 18487274
   PubMed Web of Science ®Google Scholar
• Carlson MW, Alt-Holland A, Egles C, Garlick JA. Three-dimensional tissue models of normal and diseased skin. Curr Protoc Cell Biol 2008; Chapter 19:Unit 19.9; PMID: 19085986
   PubMedGoogle Scholar